Barclays analyst Benjamin Budish lowered the firm’s price target on CME Group (CME) to $298 from $299 and keeps an Equal Weight rating on the shares. The company reported a Q2 earnings beat but is facing tough compares in Q3, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME: